Peripartum Cardiomyopathy: From Pathophysiology to Management covers the pathophysiology and the heterogenous mode of presentation of PPCM to assist in risk stratification and provide a guide for the acute and long-term management of women affected by this serious condition. Each chapter provides structured figures and practical algorithms as well as prints of electrocardiograms, echocardiographic, MRI images and several case studies throughout. This title is a must have reference for those doing basic research in this area as well as all healthcare providers caring for peripartum women, including obstetricians, general physicians, cardiologists, intensivists, as well as nurses caring for heart failure patients. Delivers figures, case studies and algorithms that facilitate understanding of this condition and guide acute and chronic management Provides guidance on the long-term prognosis and risk-stratification related to subsequent pregnancies Contains contributions from international experts in the field who have worked together for more than 10 years via the Heart Failure Association of the European Society of Cardiology, and through participation in the EuroOberservational Research program
Myocarditis is a clinical syndrome, most frequently of infectious etiology, that occurs with a broad range of relatively non-specific symptoms, and consists of an inflammatory process of the heart with necrosis and degeneration of the myocardium by inflammatory infiltration of immune cells. The infection can cause direct injury of cardiomyocytes as well as immune-mediated destruction of the myocardium, leading to cardiac dysfunction. In this book, the broad aspects of myocarditis are fully presented by leading international experts. The texts are devoted to both clinical aspects and pathophysiology, and they present comprehensive reviews of the causes of myocarditis, its classification, diagnosis, and treatment, as well as myocarditis in special populations such as pediatric, peripartum and chronic chagasic myocarditis.
|Author||: Daniel J. Garry,Robert F. Wilson,Zeev Vlodaver|
|Release Date||: 2017-06-01|
|ISBN 10||: 3319445774|
|Pages||: 572 pages|
This book is a comprehensive overview of heart failure and cardiac transplantation and integrates scientific and clinical information about the physiology, pathophysiology, diagnosis, and treatment of this disorder. Organized into five parts, it reviews the history and basic mechanisms of heart failure; etiology of heart failure; heart failure disease progression; advanced therapies for heart failure; and cardiac transplantation. The book presents basic concepts in the physiology, molecular biology, pathology, and epidemiology of the normal and failing heart; known causes of heart failure, such as right heart failure, valvular cardiomyopathy, molecular mechanisms of sarcomeric cardiomyopathies, and neuromuscular cardiomyopathy; cardiorenal syndrome; neurohormonal activation; cardiac resynchronization, ventricular assist devices; regenerative mechanisms; orthotopic heart transplantation; early and late management of the post-transplant patient; heart transplantation and antibody-mediated rejections; heart-lung transplantation; and cardiac xenotransplantation. Featuring contributions from leaders in the fields of heart failure, cardiac transplantation, cardiac pathology, and cardiovascular molecular research, Congestive Heart Failure and Cardiac Transplantation is a valuable compendium for cardiologists, cardiothoracic surgeons, researchers, trainees, and students.
Cardiomyopathies are the most featured cardiac pathologies in the twenty-first century, that threaten public health and burden healthcare budgets. This book is composed of the main topics on pathophysiology, general forms and specific types of cardiomyopathies and it also introduces new research in the field. Specific forms with or without genetic inheritance are discussed separately to attract the readers' attention on these topics. Well-known medical follow-up strategies occur ineffective at the end-stage heart failure, however, new surgical approaches can be an alternative for these patients to get a chance at the last crossroad and to improve their life quality and survival and also to gain or prolong time until possible heart transplantation.
Addresses the challenges of managing critically ill obstetric patients, with chapters authored by intensivists/anesthesiologists and obstetricians/maternal-fetal medicine specialists.
|Author||: John Kassotis|
|Publisher||: BoD – Books on Demand|
|Release Date||: 2017-02-15|
|ISBN 10||: 9535129473|
|Pages||: 168 pages|
The world of clinical cardiac electrophysiology continues to evolve with newer and more advanced technologies to better serve our patients. In this book, titled The Role of the Clinical Cardiac Electrophysiologist in the Management of Congestive Heart Failure, authors from around the world have contributed their thoughts. Various chapters describing the use of biventricular pacing devices (CRT) in the management of patients suffering from systolic heart failure are included, with a chapter dedicated to management of CRT. A chapter describing the role of CRT in patients with Chagas disease is included. Authors describe the newer pharmaceuticals in the management of this disease and the role of catheter ablation in the management of atrial fibrillation and other arrhythmias. These topics are of great interest to clinicians at the various levels of training, and I believe this textbook gives a flavor of the expanding role of the electrophysiologist in the management of an ever-expanding patient population.
|Author||: Udi Nussinovitch|
|Publisher||: Academic Press|
|Release Date||: 2017-02-10|
|ISBN 10||: 0128032685|
|Pages||: 766 pages|
The prevalence of autoimmune diseases and rheumatic conditions is constantly increasing. Autoimmune diseases affect approximately 7-10% of the population of the United States, while more than 50,000,000 American adults suffer from some type of arthritis. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases examines the complex mechanisms relating to cardiac diseases from a pathophysiological and clinical point of view. Autoimmune rheumatic diseases can affect the coronary vessels, myocardium, pericardium, heart valves and the conduction system. The diagnosis of these unique cardiac complications necessitates medical awareness and a high index of suspicion. Increased risk of advanced atherosclerosis plays a pivotal role in the development of cardiac diseases in systemic, rheumatic and autoimmune illnesses. Yet, other complex immune medicated mechanisms may contribute to the pathogenesis. Patients' optimal care requires coordination between the primary caregiver, the rheumatologist, immunologist and cardiologist. Screening for cardiovascular risk factors, recognition of high-risk patients and identification of subclinical cardiac conditions are of great importance. Moreover, regulation of inflammation, as well as abnormal immune responses and the initiation of early treatments should be the focus of patient management. A continuous attempt to identify novel therapeutic targets and change the natural history of the underlying disease and its cardiac manifestations is in progress. The book aims at providing the readers with a state of the art collection of up to date information regarding clinically important topics based on experts' perspectives. This book was a result of an extended coordinated collaboration of one-hundred and fifty-four distinguished scientists from thirty-one countries around the globe. A review of common, as well as unusual (yet clinically significant) medical cardiac complications of prevalent rheumatic, autoimmune and inflammatory diseases. Focuses on aspects of pathophysiological processes, clinical presentations, screening tests, prognostic implications and novel therapeutic approaches. Presents an up-to-date “level of evidence and “strengths of recommendations for suggested therapies and reviews all randomized clinical trials, meta-analyses and other supporting published clinical findings.
This open access book presents a comprehensive overview of dilated cardiomyopathy, providing readers with practical guidelines for its clinical management. The first part of the book analyzes in detail the disease's pathophysiology, its diagnostic work up as well as the prognostic stratification, and illustrates the role of genetics and gene-environment interaction. The second part presents current and future treatment options, highlighting the importance of long-term and individualized treatments and follow-up. Furthermore, it discusses open issues, such as the apparent healing phenomenon, the early prognosis of arrhythmic events or the use of genetic testing in clinical practice. Offering a multidisciplinary approach for optimizing the clinical management of DCM, this book is an invaluable aid not only for the clinical cardiologists, but for all physicians involved in the care of this challenging disease. This work was published by Saint Philip Street Press pursuant to a Creative Commons license permitting commercial use. All rights not granted by the work's license are retained by the author or authors.
Advances in the understanding of cardiomyopathies and the growth of cardiology have paralleled one another. Over the years, many classification methods have been developed for cardiomyopathies based on aetiology, structural models and the functional approach. The new concepts and events that have occurred in cardiology generally and in cardiomyopathies specifically are sufficient changes to justify this book. Developments in cardiomyopathies have advanced at a rapid rate, largely because of the progress that has been made in instrumental analysis and the integration of clinical cardiology with other fields of basic research. The material in this book encompasses and blends the knowledge recently acquired in genetics, pathology and physiology with the practical matters of diagnosis and treatment.
Knowledge of intensive care medicine is growing logarithmically. In addition, intensive care units and their number of beds are increasing in hospitals. Nowadays, the average human life is prolonged due to the growth of medical knowledge and skills. Intensive care units, both as a cause and as a consequence of long-life expectancy, are increasingly important. This book contains current topics on intensive care such as critical care for neonatal, neurological, and cardiological patients; fluid management in these patients; and intensive care infections. We wish the readers find this book to be helpful.
|Author||: Jawahar L. Mehta,Jean McSweeney|
|Release Date||: 2018-03-02|
|ISBN 10||: 3319711350|
|Pages||: 361 pages|
This book reviews all aspects of the diagnosis and management of heart disease in women, covering areas such as gender differences in metabolic syndrome, hypertension and atherogenesis. Gender differences in cardiovascular diseases are widespread, but while gender medicine takes into account the effects of sex and gender on the health of women and men, traditionally, women have been underrepresented in cardiovascular clinical trials, in management of different cardiac diseases and drug use. Gender Differences in the Pathogenesis and Management of Heart Disease deals with the gender-specific differences in cardiac physiology and diseases and brings into perspective the critical significance of gender in management of cardiovascular disease presentations and management. As such it is of enormous use to all clinical staff who manage women with cardiovascular disease.
The book will provide a detailed evidence-based approach to key issues in the pathophysiology, diagnosis, and management of patients with concurrent medical issues. It will provide a clinical focus with practical advice on the prevention, diagnosis, and treatment of heart disease supported by an expert’s summary, without duplicating other texts. Each chapter will be structured similarly in the following sections: (1) Introduction, (2) Pathophysiology, (3) Diagnosis (4) Management (5) Key Points, (6) Summary of the key guidelines from professional societies where available. The recommendations will have a firm background in the AHA/ACC or ESC recommendations for the management of patients. The intention is to create a comprehensive book rather than a pocketbook or manual. We hope this book will serve as an up to date reference for the practicing clinician. Each of the approximately 40 chapters will have at most 5000 words and 5 -7 high quality figures or illustrations each. Only the highest quality authors will be recruited from the United States and Europe. The emphasis will be on depth of information yet ease of access. This necessitates an approach whereby not a single word, sentence or page of the book will be wasted. Brief where it needs to be brief, detailed where detail is required, this will be a true all-encompassing clinician reference.